The global Continuous Glucose Monitoring (CGM) System for Diabetes Management market was valued at US$ 14500 million in 2025 and is anticipated to reach US$ 30114 million by 2032, at a CAGR of 11.0% from 2026 to 2032.

Continuous Glucose Monitoring (CGM) System for Diabetes Management Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Continuous Glucose Monitoring (CGM) System for Diabetes Management competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

A continuous glucose monitoring system is a medical device and data-enabled care solution for diabetes management. It measures glucose levels continuously by placing a disposable sensor in the subcutaneous interstitial space, converting biochemical signals into time-series glucose readings, and presenting trends, rate-of-change insights, and alerts for high and low glucose events. A typical system includes a sensor, a signal transmission module, and a display endpoint such as a dedicated receiver or a mobile application, supported by analytics and reporting functions that facilitate therapy adjustment and follow-up care.

In terms of form factor, the mainstream product is a patch-worn wearable sensor. By usage mode, products commonly fall into real-time systems that automatically present readings and alerts and scan-based systems that require user-initiated checks, with a smaller segment of implantable long-wear options. The core value lies in transforming episodic point testing into continuous visibility of glucose dynamics, enabling earlier risk detection, more informed dosing and lifestyle decisions, and standardized metrics for long-term glycemic evaluation across diverse care settings.

In 2025, annual global shipments of continuous glucose monitoring (CGM) systems for diabetes management were estimated at approximately 1.6–2.4 million units. On an ex-factory basis (a practical proxy for FOB net selling value), the first-year ex-factory value per system typically ranged from around USD 900 to 1,400 per system.

Driven by the rising global diabetes burden and the shift toward more proactive glycemic control, continuous glucose monitoring systems are evolving from niche tools for highly engaged users into foundational infrastructure for broader chronic care. Continuous trend visibility and real-time risk alerts improve day-to-day decision making, increase patient engagement, and provide a scalable data backbone for clinical follow-up and remote care models. As wear comfort improves and wear duration extends, factory calibration and simplified onboarding are lowering adoption barriers. Market expansion is moving beyond type 1 diabetes into insulin-treated type 2 diabetes, and in certain markets further into wider type 2 populations where providers and payers recognize the value of preventing deterioration and acute events.

Challenges Risks and Demand Trends

Key uncertainties center on product reliability and manufacturing scalability, reimbursement and channel dynamics, and data ecosystem integration. Any quality disruption can quickly translate into safety concerns regulatory exposure and loss of trust, forcing manufacturers to sustain investment in process control and supply resilience. At the same time, intensifying competition and channel shifts toward pharmacy distribution can reshape pricing and margin profiles. On the demand side, interoperability is becoming a defining expectation as monitoring increasingly connects with insulin delivery, automated therapy workflows, and out-of-hospital digital follow-up. Buyers are raising requirements for accuracy consistency and alert performance while relying more on analytics that translate data into actionable guidance. Competition is therefore expanding from hardware specs to a combined play of algorithms ecosystem compatibility and service efficiency.

This report delivers a comprehensive overview of the global Continuous Glucose Monitoring (CGM) System for Diabetes Management market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Continuous Glucose Monitoring (CGM) System for Diabetes Management. The Continuous Glucose Monitoring (CGM) System for Diabetes Management market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Continuous Glucose Monitoring (CGM) System for Diabetes Management market comprehensively. Regional market sizes by Type, by Application, by Monitoring Mode, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Continuous Glucose Monitoring (CGM) System for Diabetes Management manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Report

Report Metric	Details
Report Name	Continuous Glucose Monitoring (CGM) System for Diabetes Management Market
Accounted market size in 2025	US$ 14500 million
Forecasted market size in 2032	US$ 30114 million
CAGR	11.0%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Patch Based Wearable Sensor Implantable Sensor Others
Segment by Monitoring Mode	Intermittently Scanned CGM Real Time CGM Implantable CGM
Segment by Patient Therapy Intensity	Intensive Insulin Therapy Basal Insulin Therapy Non Insulin Diabetes Management
Segment by Sales Channel	Retail Pharmacy Channel DME and Distributor Channel Hospital Procurement Channel
by Application	Home and Ambulatory Care Outpatient Clinic Follow Up Inpatient Glycemic Management
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Abbott Laboratories, DexCom, Inc., Medtronic plc, Senseonics Holdings, Inc., Nemaura Medical Inc., A. Menarini Diagnostics S.r.l., Sinocare Inc., Medtrum Technologies Inc., MicroTech Medical (Hangzhou) Co., Ltd., SiBionics (Shenzhen) Co., Ltd., Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Monitoring Mode, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Continuous Glucose Monitoring (CGM) System for Diabetes Management manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Continuous Glucose Monitoring (CGM) System for Diabetes Management sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Continuous Glucose Monitoring (CGM) System for Diabetes Management Market growing?

Ans: The Continuous Glucose Monitoring (CGM) System for Diabetes Management Market witnessing a CAGR of 11.0% during the forecast period 2026-2032.

What is the Continuous Glucose Monitoring (CGM) System for Diabetes Management Market size in 2032?

Ans: The Continuous Glucose Monitoring (CGM) System for Diabetes Management Market size in 2032 will be US$ 30114 million.

Who are the main players in the Continuous Glucose Monitoring (CGM) System for Diabetes Management Market report?

Ans: The main players in the Continuous Glucose Monitoring (CGM) System for Diabetes Management Market are Abbott Laboratories, DexCom, Inc., Medtronic plc, Senseonics Holdings, Inc., Nemaura Medical Inc., A. Menarini Diagnostics S.r.l., Sinocare Inc., Medtrum Technologies Inc., MicroTech Medical (Hangzhou) Co., Ltd., SiBionics (Shenzhen) Co., Ltd., Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.

What are the Application segmentation covered in the Continuous Glucose Monitoring (CGM) System for Diabetes Management Market report?

Ans: The Applications covered in the Continuous Glucose Monitoring (CGM) System for Diabetes Management Market report are Home and Ambulatory Care, Outpatient Clinic Follow Up, Inpatient Glycemic Management

What are the Type segmentation covered in the Continuous Glucose Monitoring (CGM) System for Diabetes Management Market report?

Ans: The Types covered in the Continuous Glucose Monitoring (CGM) System for Diabetes Management Market report are Patch Based Wearable Sensor, Implantable Sensor, Others

1 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Overview

1.1 Product Definition

1.2 Continuous Glucose Monitoring (CGM) System for Diabetes Management by Type

1.2.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Value by Type: 2025 vs 2032

1.2.2 Patch Based Wearable Sensor

1.2.3 Implantable Sensor

1.2.4 Others

1.3 Continuous Glucose Monitoring (CGM) System for Diabetes Management by Monitoring Mode

1.3.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Value by Monitoring Mode: 2025 vs 2032

1.3.2 Intermittently Scanned CGM

1.3.3 Real Time CGM

1.3.4 Implantable CGM

1.4 Continuous Glucose Monitoring (CGM) System for Diabetes Management by Patient Therapy Intensity

1.4.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Value by Patient Therapy Intensity: 2025 vs 2032

1.4.2 Intensive Insulin Therapy

1.4.3 Basal Insulin Therapy

1.4.4 Non Insulin Diabetes Management

1.5 Continuous Glucose Monitoring (CGM) System for Diabetes Management by Sales Channel

1.5.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Value by Sales Channel: 2025 vs 2032

1.5.2 Retail Pharmacy Channel

1.5.3 DME and Distributor Channel

1.5.4 Hospital Procurement Channel

1.6 Continuous Glucose Monitoring (CGM) System for Diabetes Management by Application

1.6.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Value by Application: 2025 vs 2032

1.6.2 Home and Ambulatory Care

1.6.3 Outpatient Clinic Follow Up

1.6.4 Inpatient Glycemic Management

1.7 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size Estimates and Forecasts

1.7.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue 2021–2032

1.7.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales 2021–2032

1.7.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Average Price (2021–2032)

1.8 Assumptions and Limitations

2 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Competition by Manufacturers

2.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Manufacturers (2021–2026)

2.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Continuous Glucose Monitoring (CGM) System for Diabetes Management, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Continuous Glucose Monitoring (CGM) System for Diabetes Management, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Continuous Glucose Monitoring (CGM) System for Diabetes Management, Product Types and Applications

2.7 Global Key Manufacturers of Continuous Glucose Monitoring (CGM) System for Diabetes Management, Date of Entry into the Industry

2.8 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Competitive Situation and Trends

2.8.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Players Market Share by Revenue

2.8.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Scenario by Region

3.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Region: 2021–2032

3.2.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Region: 2021–2026

3.2.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Region: 2027–2032

3.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Region: 2021–2032

3.3.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Region: 2021–2026

3.3.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Region: 2027–2032

3.4 North America Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Facts & Figures by Country

3.4.1 North America Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country (2021–2032)

3.4.3 North America Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Facts & Figures by Country

3.5.1 Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country (2021–2032)

3.5.3 Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Facts & Figures by Region

3.6.1 Asia Pacific Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Region (2021–2032)

3.6.3 Asia Pacific Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Facts & Figures by Country

3.7.1 Latin America Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country (2021–2032)

3.7.3 Latin America Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Facts & Figures by Country

3.8.1 Middle East and Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country (2021–2032)

3.8.3 Middle East and Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Type (2021–2032)

4.1.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Type (2021–2026)

4.1.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Type (2027–2032)

4.1.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Type (2021–2032)

4.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Type (2021–2032)

4.2.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Type (2021–2026)

4.2.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Type (2027–2032)

4.2.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Type (2021–2032)

4.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Price by Type (2021–2032)

5 Segment by Application

5.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Application (2021–2032)

5.1.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Application (2021–2026)

5.1.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Application (2027–2032)

5.1.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Application (2021–2032)

5.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Application (2021–2032)

5.2.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Application (2021–2026)

5.2.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Application (2027–2032)

5.2.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Application (2021–2032)

5.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Abbott Laboratories

6.1.1 Abbott Laboratories Company Information

6.1.2 Abbott Laboratories Description and Business Overview

6.1.3 Abbott Laboratories Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Abbott Laboratories Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolio

6.1.5 Abbott Laboratories Recent Developments/Updates

6.2 DexCom, Inc.

6.2.1 DexCom, Inc. Company Information

6.2.2 DexCom, Inc. Description and Business Overview

6.2.3 DexCom, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 DexCom, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolio

6.2.5 DexCom, Inc. Recent Developments/Updates

6.3 Medtronic plc

6.3.1 Medtronic plc Company Information

6.3.2 Medtronic plc Description and Business Overview

6.3.3 Medtronic plc Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Medtronic plc Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolio

6.3.5 Medtronic plc Recent Developments/Updates

6.4 Senseonics Holdings, Inc.

6.4.1 Senseonics Holdings, Inc. Company Information

6.4.2 Senseonics Holdings, Inc. Description and Business Overview

6.4.3 Senseonics Holdings, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Senseonics Holdings, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolio

6.4.5 Senseonics Holdings, Inc. Recent Developments/Updates

6.5 Nemaura Medical Inc.

6.5.1 Nemaura Medical Inc. Company Information

6.5.2 Nemaura Medical Inc. Description and Business Overview

6.5.3 Nemaura Medical Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Nemaura Medical Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolio

6.5.5 Nemaura Medical Inc. Recent Developments/Updates

6.6 A. Menarini Diagnostics S.r.l.

6.6.1 A. Menarini Diagnostics S.r.l. Company Information

6.6.2 A. Menarini Diagnostics S.r.l. Description and Business Overview

6.6.3 A. Menarini Diagnostics S.r.l. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 A. Menarini Diagnostics S.r.l. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolio

6.6.5 A. Menarini Diagnostics S.r.l. Recent Developments/Updates

6.7 Sinocare Inc.

6.7.1 Sinocare Inc. Company Information

6.7.2 Sinocare Inc. Description and Business Overview

6.7.3 Sinocare Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Sinocare Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolio

6.7.5 Sinocare Inc. Recent Developments/Updates

6.8 Medtrum Technologies Inc.

6.8.1 Medtrum Technologies Inc. Company Information

6.8.2 Medtrum Technologies Inc. Description and Business Overview

6.8.3 Medtrum Technologies Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Medtrum Technologies Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolio

6.8.5 Medtrum Technologies Inc. Recent Developments/Updates

6.9 MicroTech Medical (Hangzhou) Co., Ltd.

6.9.1 MicroTech Medical (Hangzhou) Co., Ltd. Company Information

6.9.2 MicroTech Medical (Hangzhou) Co., Ltd. Description and Business Overview

6.9.3 MicroTech Medical (Hangzhou) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 MicroTech Medical (Hangzhou) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolio

6.9.5 MicroTech Medical (Hangzhou) Co., Ltd. Recent Developments/Updates

6.10 SiBionics (Shenzhen) Co., Ltd.

6.10.1 SiBionics (Shenzhen) Co., Ltd. Company Information

6.10.2 SiBionics (Shenzhen) Co., Ltd. Description and Business Overview

6.10.3 SiBionics (Shenzhen) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 SiBionics (Shenzhen) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolio

6.10.5 SiBionics (Shenzhen) Co., Ltd. Recent Developments/Updates

6.11 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.

6.11.1 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Company Information

6.11.2 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Description and Business Overview

6.11.3 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolio

6.11.5 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Continuous Glucose Monitoring (CGM) System for Diabetes Management Industry Chain Analysis

7.2 Continuous Glucose Monitoring (CGM) System for Diabetes Management Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Mode & Process Analysis

7.4 Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales and Marketing

7.4.1 Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Channels

7.4.2 Continuous Glucose Monitoring (CGM) System for Diabetes Management Distributors

7.5 Continuous Glucose Monitoring (CGM) System for Diabetes Management Customer Analysis

8 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Dynamics

8.1 Continuous Glucose Monitoring (CGM) System for Diabetes Management Industry Trends

8.2 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Drivers

8.3 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Challenges

8.4 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Dexcom

Medtronic Inc

Abbott Laboratories

Senseonics Holdings, Inc.

Nemaura Medical, Inc

A. Menarini Diagnostics

Sinocare

Medtrum Technologies Inc.

MicroTech Medical (Hangzhou) Co., Ltd

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd

SiBionics (Shenzhen) Co., Ltd.

List of Tables

Table 1. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Value by Monitoring Mode (US$ Million), 2025 vs 2032

Table 3. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Value by Patient Therapy Intensity (US$ Million), 2025 vs 2032

Table 4. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Value by Sales Channel (US$ Million), 2025 vs 2032

Table 5. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Value by Application (US$ Million), 2025 vs 2032

Table 6. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Competitive Situation by Manufacturers in 2025

Table 7. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units) of Key Manufacturers (2021–2026)

Table 8. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Manufacturers (2021–2026)

Table 9. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue (US$ Million) by Manufacturers (2021–2026)

Table 10. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Share by Manufacturers (2021–2026)

Table 11. Global Market Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 12. Global Key Players of Continuous Glucose Monitoring (CGM) System for Diabetes Management, Industry Ranking, 2023 vs 2024 vs 2025

Table 13. Global Key Manufacturers of Continuous Glucose Monitoring (CGM) System for Diabetes Management, Manufacturing Sites and Headquarters

Table 14. Global Key Manufacturers of Continuous Glucose Monitoring (CGM) System for Diabetes Management, Product Types and Applications

Table 15. Global Key Manufacturers of Continuous Glucose Monitoring (CGM) System for Diabetes Management, Date of Entry into the Industry

Table 16. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 17. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Companies by Tier (Tier 1, Tier 2, Tier 3), based on Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue, 2025

Table 18. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 19. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 20. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Region (K Units), 2021–2026

Table 21. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Region (2021–2026)

Table 22. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Region (K Units), 2027–2032

Table 23. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Region (2027–2032)

Table 24. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Region (US$ Million), 2021–2026

Table 25. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Region (2021–2026)

Table 26. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Region (US$ Million), 2027–2032

Table 27. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Region (2027–2032)

Table 28. North America Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 29. North America Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country (K Units), 2021–2026

Table 30. North America Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country (K Units), 2027–2032

Table 31. North America Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country (US$ Million), 2021–2026

Table 32. North America Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country (US$ Million), 2027–2032

Table 33. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 34. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country (K Units), 2021–2026

Table 35. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country (K Units), 2027–2032

Table 36. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country (US$ Million), 2021–2026

Table 37. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country (US$ Million), 2027–2032

Table 38. Asia Pacific Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 39. Asia Pacific Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Region (K Units), 2021–2026

Table 40. Asia Pacific Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Region (K Units), 2027–2032

Table 41. Asia Pacific Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Region (US$ Million), 2021–2026

Table 42. Asia Pacific Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Region (US$ Million), 2027–2032

Table 43. Latin America Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 44. Latin America Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country (K Units), 2021–2026

Table 45. Latin America Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country (K Units), 2027–2032

Table 46. Latin America Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country (US$ Million), 2021–2026

Table 47. Latin America Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country (US$ Million), 2027–2032

Table 48. Middle East and Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 49. Middle East and Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country (K Units), 2021–2026

Table 50. Middle East and Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country (K Units), 2027–2032

Table 51. Middle East and Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country (US$ Million), 2021–2026

Table 52. Middle East and Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country (US$ Million), 2027–2032

Table 53. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units) by Type (2021–2026)

Table 54. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units) by Type (2027–2032)

Table 55. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Type (2021–2026)

Table 56. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Type (2027–2032)

Table 57. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue (US$ Million) by Type (2021–2026)

Table 58. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue (US$ Million) by Type (2027–2032)

Table 59. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Type (2021–2026)

Table 60. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Type (2027–2032)

Table 61. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Price (US$/Unit) by Type (2021–2026)

Table 62. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Price (US$/Unit) by Type (2027–2032)

Table 63. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units) by Application (2021–2026)

Table 64. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units) by Application (2027–2032)

Table 65. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Application (2021–2026)

Table 66. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Application (2027–2032)

Table 67. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue (US$ Million) by Application (2021–2026)

Table 68. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue (US$ Million) by Application (2027–2032)

Table 69. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Application (2021–2026)

Table 70. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Application (2027–2032)

Table 71. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Price (US$/Unit) by Application (2021–2026)

Table 72. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Price (US$/Unit) by Application (2027–2032)

Table 73. Abbott Laboratories Company Information

Table 74. Abbott Laboratories Description and Business Overview

Table 75. Abbott Laboratories Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 76. Abbott Laboratories Continuous Glucose Monitoring (CGM) System for Diabetes Management Product

Table 77. Abbott Laboratories Recent Developments/Updates

Table 78. DexCom, Inc. Company Information

Table 79. DexCom, Inc. Description and Business Overview

Table 80. DexCom, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 81. DexCom, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product

Table 82. DexCom, Inc. Recent Developments/Updates

Table 83. Medtronic plc Company Information

Table 84. Medtronic plc Description and Business Overview

Table 85. Medtronic plc Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 86. Medtronic plc Continuous Glucose Monitoring (CGM) System for Diabetes Management Product

Table 87. Medtronic plc Recent Developments/Updates

Table 88. Senseonics Holdings, Inc. Company Information

Table 89. Senseonics Holdings, Inc. Description and Business Overview

Table 90. Senseonics Holdings, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 91. Senseonics Holdings, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product

Table 92. Senseonics Holdings, Inc. Recent Developments/Updates

Table 93. Nemaura Medical Inc. Company Information

Table 94. Nemaura Medical Inc. Description and Business Overview

Table 95. Nemaura Medical Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 96. Nemaura Medical Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product

Table 97. Nemaura Medical Inc. Recent Developments/Updates

Table 98. A. Menarini Diagnostics S.r.l. Company Information

Table 99. A. Menarini Diagnostics S.r.l. Description and Business Overview

Table 100. A. Menarini Diagnostics S.r.l. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 101. A. Menarini Diagnostics S.r.l. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product

Table 102. A. Menarini Diagnostics S.r.l. Recent Developments/Updates

Table 103. Sinocare Inc. Company Information

Table 104. Sinocare Inc. Description and Business Overview

Table 105. Sinocare Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 106. Sinocare Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product

Table 107. Sinocare Inc. Recent Developments/Updates

Table 108. Medtrum Technologies Inc. Company Information

Table 109. Medtrum Technologies Inc. Description and Business Overview

Table 110. Medtrum Technologies Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 111. Medtrum Technologies Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product

Table 112. Medtrum Technologies Inc. Recent Developments/Updates

Table 113. MicroTech Medical (Hangzhou) Co., Ltd. Company Information

Table 114. MicroTech Medical (Hangzhou) Co., Ltd. Description and Business Overview

Table 115. MicroTech Medical (Hangzhou) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 116. MicroTech Medical (Hangzhou) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product

Table 117. MicroTech Medical (Hangzhou) Co., Ltd. Recent Developments/Updates

Table 118. SiBionics (Shenzhen) Co., Ltd. Company Information

Table 119. SiBionics (Shenzhen) Co., Ltd. Description and Business Overview

Table 120. SiBionics (Shenzhen) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 121. SiBionics (Shenzhen) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product

Table 122. SiBionics (Shenzhen) Co., Ltd. Recent Developments/Updates

Table 123. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Company Information

Table 124. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Description and Business Overview

Table 125. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 126. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product

Table 127. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Recent Developments/Updates

Table 128. Key Raw Materials Lists

Table 129. Raw Materials Key Suppliers Lists

Table 130. Continuous Glucose Monitoring (CGM) System for Diabetes Management Distributors List

Table 131. Continuous Glucose Monitoring (CGM) System for Diabetes Management Customers List

Table 132. Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Trends

Table 133. Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Drivers

Table 134. Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Challenges

Table 135. Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Restraints

Table 136. Research Programs/Design for This Report

Table 137. Key Data Information from Secondary Sources

Table 138. Key Data Information from Primary Sources

Table 139. Authors List of This Report

List of Figures

Figure 1. Product Picture of Continuous Glucose Monitoring (CGM) System for Diabetes Management

Figure 2. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Share by Type: 2025 & 2032

Figure 4. Patch Based Wearable Sensor Product Picture

Figure 5. Implantable Sensor Product Picture

Figure 6. Others Product Picture

Figure 7. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Value by Monitoring Mode (US$ Million), 2021–2032

Figure 8. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Share by Monitoring Mode: 2025 vs 2032

Figure 9. Intermittently Scanned CGM Product Picture

Figure 10. Real Time CGM Product Picture

Figure 11. Implantable CGM Product Picture

Figure 12. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Value by Patient Therapy Intensity (US$ Million), 2021–2032

Figure 13. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Share by Patient Therapy Intensity: 2025 vs 2032

Figure 14. Intensive Insulin Therapy Product Picture

Figure 15. Basal Insulin Therapy Product Picture

Figure 16. Non Insulin Diabetes Management Product Picture

Figure 17. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Value by Sales Channel (US$ Million), 2021–2032

Figure 18. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Share by Sales Channel: 2025 vs 2032

Figure 19. Retail Pharmacy Channel Product Picture

Figure 20. DME and Distributor Channel Product Picture

Figure 21. Hospital Procurement Channel Product Picture

Figure 22. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Value by Application (US$ Million), 2021–2032

Figure 23. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Share by Application: 2025 & 2032

Figure 24. Home and Ambulatory Care

Figure 25. Outpatient Clinic Follow Up

Figure 26. Inpatient Glycemic Management

Figure 27. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 28. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size (US$ Million), 2021–2032

Figure 29. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), 2021–2032

Figure 30. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price (US$/Unit), 2021–2032

Figure 31. Continuous Glucose Monitoring (CGM) System for Diabetes Management Report Years Considered

Figure 32. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Share by Manufacturers in 2025

Figure 33. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Share by Manufacturers in 2025

Figure 34. Top 5 and Top 10 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Players: Market Share by Revenue in Continuous Glucose Monitoring (CGM) System for Diabetes Management in 2025

Figure 35. Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 36. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 37. North America Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Country (2021–2032)

Figure 38. North America Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Country (2021–2032)

Figure 39. United States Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Canada Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Country (2021–2032)

Figure 42. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Country (2021–2032)

Figure 43. Germany Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. France Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. U.K. Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Italy Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Russia Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Asia Pacific Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Region (2021–2032)

Figure 49. Asia Pacific Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Region (2021–2032)

Figure 50. China Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Japan Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. South Korea Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. India Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Australia Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. China Taiwan Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth Rate (US$ Million), 2021–2032

Figure 56. Indonesia Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth Rate (US$ Million), 2021–2032

Figure 57. Thailand Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth Rate (US$ Million), 2021–2032

Figure 58. Malaysia Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth Rate (US$ Million), 2021–2032

Figure 59. Latin America Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Country (2021–2032)

Figure 60. Latin America Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Country (2021–2032)

Figure 61. Mexico Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth Rate (US$ Million), 2021–2032

Figure 62. Brazil Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth Rate (US$ Million), 2021–2032

Figure 63. Argentina Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth Rate (US$ Million), 2021–2032

Figure 64. Middle East and Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Country (2021–2032)

Figure 65. Middle East and Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Country (2021–2032)

Figure 66. Turkey Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth Rate (US$ Million), 2021–2032

Figure 67. Saudi Arabia Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth Rate (US$ Million), 2021–2032

Figure 68. UAE Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth Rate (US$ Million), 2021–2032

Figure 69. Global Sales Market Share of Continuous Glucose Monitoring (CGM) System for Diabetes Management by Type (2021–2032)

Figure 70. Global Revenue Market Share of Continuous Glucose Monitoring (CGM) System for Diabetes Management by Type (2021–2032)

Figure 71. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Price (US$/Unit) by Type (2021–2032)

Figure 72. Global Sales Market Share of Continuous Glucose Monitoring (CGM) System for Diabetes Management by Application (2021–2032)

Figure 73. Global Revenue Market Share of Continuous Glucose Monitoring (CGM) System for Diabetes Management by Application (2021–2032)

Figure 74. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Price (US$/Unit) by Application (2021–2032)

Figure 75. Continuous Glucose Monitoring (CGM) System for Diabetes Management Value Chain

Figure 76. Channels of Distribution (Direct Vs Distribution)

Figure 77. Bottom-up and Top-down Approaches for This Report

Figure 78. Data Triangulation

Figure 79. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Continuous Glucose Monitoring CGM Technology Market Research Report 2024

Continuous Blood Glucose Monitoring Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Continuous Non invasive Glucose Monitoring System for Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Diabetes Management Insulin Pump and Continuous Glucose Monitors CGM Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Continuous Glucose Monitoring CGM Sensors Market Research Report 2025

Continuous Glucose Monitoring System for Elderly Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Continuous Blood Glucose Monitoring Devices Market Research Report 2025

Non invasive Continuous Glucose Monitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Wearable Glucose Monitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Glucose Meters Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Non Invasive Blood Glucose Monitoring System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Continuous Glucose Monitoring Devices Market Insights Forecast to 2030

Global Glucose Monitor Market Research Report 2024

Home Use CGM System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Portable Blood Glucose Meter Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Networked Glucose Meter Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Continuous Glucose Monitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Self Monitoring Blood Glucose System Market Research Report 2024

Smart Continuous Glucose Monitoring System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions